Latest News

We feel now is a pretty good time to analyse Airtasker Limited's ( ASX:ART ) business as it appears the company may be...

In October 2025, Alphabet Inc. announced a 25-year agreement with NextEra Energy to restart Iowa’s Duane Arnold nuclear facility, providing carbon-free power for Google’s expanding AI and cloud needs. This partnership illustrates how major technology companies are driving demand for clean energy infrastructure, spotlighting NextEra’s ability to serve large-scale customers in the evolving electricity market. We’ll now explore how supplying nuclear energy for Google’s AI operations could...

Klil Industries (TASE:KLIL) just released its Q3 2025 results, reporting total revenue of ₪100.8 million and basic EPS of ₪1.52. Over the past year, the company’s revenue has moved from ₪68.3 million in Q2 2024 to the current quarter’s ₪100.8 million. Basic EPS changed from ₪0.65 in Q2 2024 to ₪1.52 this quarter, showing notable fluctuations in recent quarters. With net profit margins tightening to just 0.5% and consistent pressure on earnings, the latest figures will keep investors focused...

In late November 2025, Sigma Lithium showcased its Quintuple Zero ESG model and advanced sustainable mining practices at COP30 in Belém, Brazil, emphasizing Brazil's growing role in the global lithium supply chain. An interesting takeaway is Sigma Lithium’s effort to set an international benchmark for environmentally responsible lithium production, positioning its Jequitinhonha Valley operations as a model for low-carbon, socially responsible supply chains in the mining sector. We'll...

Ever wondered if Kinsale Capital Group is a bargain in today’s market? You’re not alone. Let’s see if there’s value hiding beneath the surface. Kinsale’s stock dropped 2.4% in the past week, is down 5.6% this month, and has slid 17.0% year-to-date, which may signal shifting market sentiment or a chance for patient investors. Recently, media coverage has focused on Kinsale’s strategic expansion into specialty insurance lines and its prudent risk management approach. These developments are...

TIC Solutions, Inc. recently presented at the UBS Global Industrials and Transportation Conference, held at Eau Palm Beach Resort and Spa in Manalapan, Florida, United States on December 2, 2025. Investor interest is focused on potential updates or announcements arising from TIC Solutions' participation at this prominent industry event. We'll assess how the anticipation surrounding TIC Solutions' conference presentation may influence the company's investment narrative and outlook. Trump has...

Ever wondered if Centerra Gold is truly a bargain, or if you might be catching the stock just as it takes off? You are not alone in wanting to know whether it is time to jump in, hold, or wait for a better entry point. Shares have surged impressively, climbing 6.7% over the last week, up 13.1% in the last month, and delivering a staggering 119% year-to-date return. This kind of run grabs attention and raises questions about whether the rally can last. Fueling this momentum, Centerra Gold...

Insiders who bought Bio-Gene Technology Limited ( ASX:BGT ) stock lover the last 12 months are probably not as affected...

Atour Lifestyle Holdings (NasdaqGS:ATAT) just released its third quarter results, reporting higher revenue and net income compared to last year. The company also raised its full-year outlook and declared a second cash dividend. See our latest analysis for Atour Lifestyle Holdings. After climbing on the back of upbeat earnings, a dividend announcement, and plans for accelerated expansion, Atour Lifestyle Holdings has attracted plenty of market attention. The latest share price closed at...

T. Rowe Price Group recently launched four new active fixed income ETFs, including short-term, long-term, and high yield municipal bond strategies, as well as a multi-sector income offering, all now trading on the NASDAQ exchange. This expansion brings the firm’s active ETF lineup to 28 products, reflecting a continued focus on meeting investor demand for diversified, actively managed fixed income solutions and broadening its presence in the ETF market. We’ll examine how the rollout of new...

Perfect (PERF) has been attracting some attention lately, given its recent performance in the software sector. With a focus on artificial intelligence solutions for beauty and fashion, investors are taking stock of how its strategies could shape future returns. See our latest analysis for Perfect. Perfect’s share price has faced stiff headwinds this year, currently sitting at $1.83 after a 37% year-to-date decline. While investors saw a brief 7.65% bump in the last week, the longer-term...

In late November 2025, reports indicated that Aegon Ltd. had been exploring the potential divestment of certain non-US units, including Aegon UK and its majority stake in a Spanish and Portuguese joint venture with Banco Santander, as part of a shift to focus on its U.S. business. This shift highlights Aegon’s intent to streamline its operations and concentrate resources on areas with stronger demographic trends and rising demand for retirement and insurance solutions in the United...

Carmel (TASE:CRML) just released its Q3 2025 results, posting revenue of 147.49 million ILS and basic EPS of -0.12 ILS for the quarter. The company has seen revenue fluctuate over recent periods, from 143.05 million ILS in Q3 2024 to 110.05 million ILS in Q2 2025, while EPS moved from 0.66 ILS last year to negative territory this quarter. Operating margins remain under pressure and the latest results keep profitability firmly in focus for investors. See our full analysis for Carmel. Now let’s...

TGS (OB:TGS), a leading provider of geoscience data services, has seen its stock move in recent sessions. Many investors are now reevaluating the company’s performance, particularly as its recent returns differ from sector trends. See our latest analysis for TGS. TGS’s share price has struggled to find momentum recently, with a 27.3% decline year-to-date and a one-year total shareholder return of -17.05% putting performance behind sector expectations. A modest 8.6% gain over the past three...

BYD (SEHK:1211) shares showed modest movement today, drawing investor attention after the company posted updated figures on vehicle deliveries. Recent trends in the electric vehicle sector, along with these latest numbers, have prompted closer scrutiny of BYD’s growth prospects. See our latest analysis for BYD. Investor sentiment appears to be rebounding for BYD, with the latest delivery update helping to sustain momentum from earlier in the year. Although the 1-day and 7-day share price...

Halliburton recently appointed Mr. Timothy A. Leach, a seasoned executive from ConocoPhillips, to its board of directors, alongside announcing a fourth quarter 2025 dividend of US$0.17 per share payable on December 24, 2025. This combination of leadership expertise and commitment to shareholder returns underscores Halliburton’s focus on strong governance and sustainable capital management. Next, we'll consider how the addition of Mr. Leach to the board strengthens Halliburton’s long-term...

Curious if Nutrien’s stock lives up to the hype or if it is just experiencing a temporary surge? Let’s explore whether today’s price offers real value. Shares have been rising recently, gaining 5.2% in the past week and 10.3% over the last month. This has contributed to a year-to-date increase of 29.1%. Market attention increased after Nutrien made moves to streamline operations and focus on its most profitable business segments, along with growing demand for fertilizers in global...

EssilorLuxottica recently announced the formation of its Scientific Advisory Committee, bringing together five renowned experts, including Nobel and Fields medal laureates, to provide strategic scientific guidance across fields such as ophthalmology, optics, audiology, AI, and bioethics. This move strengthens EssilorLuxottica’s scientific foundation and highlights its focus on pioneering research and innovation in eye health and technology. We'll explore how the appointment of globally...

Harmony Biosciences Holdings (HRMY) has just reported a pair of meaningful updates for investors. The company announced positive results from its pivotal bioequivalence study of pitolisant's gastro-resistant formulation, as well as the start of a Phase 1 trial for a new orexin 2 receptor agonist. See our latest analysis for Harmony Biosciences Holdings. Harmony Biosciences Holdings has caught fresh attention, thanks to the momentum around its positive trial results and pipeline news, which...

Wondering if Canadian National Railway shares are trading at a bargain, or if they are expensive for what you get? Let's dig into where things stand right now. In the last week, the stock is up 2.4%, but after a soft performance this year it is still down 8.8% year-to-date and 10.7% over the past year. Recent headlines highlight Canada's rail sector navigating industry-wide challenges, especially related to supply chain disruptions and shifting commodity prices. These factors have spurred...

The appointment of Stacy Minero as Chief Marketing & Experience Officer at OUTFRONT Media (OUT) is attracting fresh interest from investors. Minero brings an impressive track record in creative campaigns and brand strategy across major tech and media firms. See our latest analysis for OUTFRONT Media. OUTFRONT Media's latest C-suite addition builds on a period of strong momentum. After announcing leadership changes and presenting at a major industry conference, OUTFRONT's share price has...

Ever wondered if U.S. Bancorp is trading at a bargain or if its price has already moved ahead of its true value? You are not alone. Investors everywhere are looking for clarity in today’s market. After a steady climb, shares are up 1.0% over the past week and have gained 5.8% in the last month, but the stock remains nearly flat over the year, dipping just -0.9%. Recent headlines have put traditional banks like U.S. Bancorp in the spotlight, as the industry grapples with evolving regulatory...

Tyra Biosciences recently appointed Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer, both joining from major biopharmaceutical companies and bringing extensive commercial and regulatory leadership experience. This infusion of talent draws from executives with proven success in product launches and regulatory approvals, reflecting a focused effort to advance Tyra's pipeline initiatives. We'll explore how Heather Faulds’s leadership in global regulatory...

Kering (ENXTPA:KER) shares have drifted slightly lower over the past week, continuing a gradual downward trend this month. Investors seem to be weighing recent performance and broader market sentiment as the company’s stock reacts in line with sector dynamics. See our latest analysis for Kering. While Kering’s shares remain subdued in the short term, it is worth noting that the stock has rebounded strongly since the start of the year, with a year-to-date share price return of nearly 25%...